261 related articles for article (PubMed ID: 16756225)
1. [From gene to disease; the PABN1 gene and oculopharyngeal muscular dystrophy].
Schreuder AH; de Die-Smulders CE; Herbergs J; Koehler PJ
Ned Tijdschr Geneeskd; 2006 May; 150(20):1124-6. PubMed ID: 16756225
[TBL] [Abstract][Full Text] [Related]
2. Oculopharyngeal muscular dystrophy.
Brais B; Rouleau GA; Bouchard JP; Fardeau M; Tomé FM
Semin Neurol; 1999; 19(1):59-66. PubMed ID: 10711989
[TBL] [Abstract][Full Text] [Related]
3. PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy.
Shanmugam V; Dion P; Rochefort D; Laganière J; Brais B; Rouleau GA
Ann Neurol; 2000 Nov; 48(5):798-802. PubMed ID: 11079546
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.
Dion P; Shanmugam V; Gaspar C; Messaed C; Meijer I; Toulouse A; Laganiere J; Roussel J; Rochefort D; Laganiere S; Allen C; Karpati G; Bouchard JP; Brais B; Rouleau GA
Neurobiol Dis; 2005 Apr; 18(3):528-36. PubMed ID: 15755680
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
Bae JS; Ki CS; Kim JW; Kim BJ
J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
[TBL] [Abstract][Full Text] [Related]
6. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
[TBL] [Abstract][Full Text] [Related]
9. Intranuclear inclusions in oculopharyngeal muscular dystrophy contain poly(A) binding protein 2.
Becher MW; Kotzuk JA; Davis LE; Bear DG
Ann Neurol; 2000 Nov; 48(5):812-5. PubMed ID: 11079550
[TBL] [Abstract][Full Text] [Related]
10. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
[TBL] [Abstract][Full Text] [Related]
11. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological study of a case of oculopharyngeal muscular dystrophy].
Moreno Martínez JM; Martín Araguz A; García de la Rocha ML; Masjuán Vallejo J; Barón Rubio M; Ginel Feito MD
Arch Neurobiol (Madr); 1991; 54(5):229-32. PubMed ID: 1804038
[TBL] [Abstract][Full Text] [Related]
13. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
van der Sluijs BM; van Engelen BG; Hoefsloot LH
Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
[TBL] [Abstract][Full Text] [Related]
14. [A family with oculopharyngeal muscular dystrophy with (GCG)9 expansion in which a sister had neck as well as proximal and her brother proximal lower limb muscle weakness].
Takahashi T; Tateyama M; Aoki M; Shiga Y; Uyama E; Itoyama Y
Rinsho Shinkeigaku; 2000 Sep; 40(9):911-4. PubMed ID: 11257788
[TBL] [Abstract][Full Text] [Related]
15. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
[TBL] [Abstract][Full Text] [Related]
16. [Familial chronic progressive blepharoptosis without other neurological symptoms: a new clinical entity?].
Ichikawa H; Sugita K; Nonaka A; Watanabe Y; Nonaka I
Rinsho Shinkeigaku; 2002 Jan; 42(1):1-6. PubMed ID: 12355844
[TBL] [Abstract][Full Text] [Related]
17. Effect of oculopharyngeal muscular dystrophy-associated extension of seven alanines on the fibrillation properties of the N-terminal domain of PABPN1.
Lodderstedt G; Hess S; Hause G; Scheuermann T; Scheibel T; Schwarz E
FEBS J; 2007 Jan; 274(2):346-55. PubMed ID: 17229142
[TBL] [Abstract][Full Text] [Related]
18. Oculopharyngeal and distal myopathy: a case study from Papua New Guinea.
Scrimgeour EM; Mastaglia FL
Am J Med Genet; 1984 Apr; 17(4):763-71. PubMed ID: 6720743
[TBL] [Abstract][Full Text] [Related]
19. [Oculopharyngeal muscular dystrophy].
Tamir G; Hauben D
Harefuah; 1990 Jun; 118(11):634-6. PubMed ID: 2387559
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial abnormalities in oculopharyngeal muscular dystrophy.
Wong KT; Dick D; Anderson JR
Neuromuscul Disord; 1996 May; 6(3):163-6. PubMed ID: 8784803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
